Usana Health Sciences (USNA) Receivables (2013 - 2026)

Usana Health Sciences (USNA) has 12 years of Receivables data on file, last reported at $9.7 million in Q2 2026.

• On a quarterly basis, Receivables changed N/A year-over-year to $9.7 million in Q2 2026; TTM through Apr 2026 was $9.7 million, a N/A change from a year earlier, with the FY2026 full-year figure at $12.4 million, up 66.79% from the prior year.
• Receivables for Q2 2026 stood at $9.7 million, down from $12.4 million in the prior quarter.
• Over the last five years, Receivables for USNA reached as high as $12.4 million in Q1 2026 and fell as low as $5.2 million in Q4 2022.
• Historically, Receivables has averaged $7.7 million across 4 years, with a median of $6.8 million in 2023.
• Across the five-year window, Receivables decreased 10.68% in 2022 and surged 66.79% in 2026, its largest moves.
• Year by year, Receivables stood at $5.2 million in 2022, then increased by 19.08% to $6.2 million in 2023, then advanced by 20.2% to $7.4 million in 2024, then jumped by 30.17% to $9.7 million in 2026.
• Per Business Quant data, the three most recent Receivables figures were $9.7 million in Q2 2026, $12.4 million in Q1 2026, and $7.4 million in Q4 2024.